FMO5 and familial dilated cardiomyopathy: Similarly, YAP RNAi silencing in LV-YAP-shRNA group could obviously decrease the activity of NADPH oxidase in the LV-YAP-shRNA group compared with the DCM group and LV-SC-shRNA group (Fig. 6K, p < 0.01).